Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institut Jean-Godinot is a leading comprehensive cancer center located in Reims, France, and is a prominent member of the UNICANCER network. As a private non-profit hospital of public interest (ESPIC), it provides a full spectrum of oncology services, including advanced diagnostics, surgery, radiotherapy, and medical oncology. The institute is particularly distinguished by its expertise in nuclear medicine, housing an on-site cyclotron for the production and research of medical isotopes and radiopharmaceuticals. It maintains a robust clinical research infrastructure, participating in numerous international clinical trials and academic studies to advance cancer treatment. Through its integration of patient care, teaching, and translational research, the institute serves as a regional hub for oncological innovation in the Grand Est region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut Jean-Godinot.